2 New Hires, 1 Promotion Strengthen Core Investment Banking Expertise and Position Independent Investment Bank for Future Success

Bailey & Company, one of the country’s largest independent healthcare-focused investment banks serving lower-middle and middle market companies, announced today two new hires and one promotion that will support the organization’s growth into the medical technology and supply chain sectors and enhance its core investment banking capabilities.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030181721/en/

Peter Machmeier has joined Bailey & Company as a managing director, focusing on medical devices and products, contract manufacturing and medical equipment services sectors.

Peter Machmeier has joined the organization as a managing director, focusing on medical devices and products, contract manufacturing and medical equipment services sectors. Before joining Bailey & Company, Peter held various investment banking roles at Kroll (formerly Duff & Phelps) and Doughtery & Company. Most recently, Peter was a managing director at Kroll focused on the medical technology and supply chain subsectors.

“Bailey & Company has increased its market profile in recent years, and I’m proud to be joining a growing platform dedicated to the healthcare industry,” Machmeier said. “By adding the medical technology and supply chain sectors to its existing four areas of expertise, Bailey & Company can serve new and existing clients in even more meaningful ways going forward.”

Brian Jones has joined the organization as director, enhancing Bailey & Company’s growing pharma services and life sciences practices. Brian brings a unique combination of professional experience in healthcare services investment banking, management consulting and military service to the organization. Prior to joining Bailey & Company, Brian held senior investment banking roles at Jefferies and Harris Williams.

“I’m excited to join Bailey & Company’s dynamic healthcare-focused investment banking platform,” Jones said. “The organization’s more than 20 years of healthcare M&A experience, proprietary research capabilities and deep relationships across the healthcare ecosystem provide a unique market perspective and strengthen our ability to serve as trusted M&A advisors to our founder and middle-market healthcare investor clients.”

Cray Yoo was promoted to director at Bailey & Company, focusing on the organization’s healthcare IT & tech-enabled services and payer services sectors. Cray brings a combination of investment banking, corporate strategy and corporate development work to the organization from prior roles at Kroll’s healthcare investment banking group and corporate development at HMS, a technology analytics and engagement solution for healthcare payers.

“I’m excited to be part of Bailey & Company’s continued growth,” Yoo said. “I have experienced firsthand the impact of our M&A advisory capabilities and the positive outcomes we create for our clients. I look forward to collaborating with my new colleagues as we continue to create new opportunities in the coming years.”

“Bailey & Company has been on a growth journey for several years now,” said Tim Scallen, chief executive officer. “Over the last three years, we have invested in our business to better support our clients and fuel the innovation that is making the healthcare system work better for everyone. These new team moves are the next step in our business evolution, and I am excited to see the contributions of Peter, Brian and Cray as they engage the industry and collaborate with our clients.”

Since 2023, Bailey & Company has advised more than 30 investment banking transactions and added the skills and experience of 20 new investment bankers. Additionally, the firm has published 16 research notes and reports since launching its market development capabilities in 2025, while also increasing its presence and profile at healthcare industry conferences across the country.

About Bailey & Company

Bailey & Company is a Nashville-based merchant banking platform focused on middle market healthcare companies in the healthcare services, healthcare technology, payer services and pharma services/medtech/life sciences sectors. As one of the largest independent, sector-focused investment banking and investing platforms in the country, Bailey & Company supports strong management teams that have built scalable platforms by providing strategic insights, world-class advice and access to one of the most diverse networks of industry experts. For more information see: www.bnco.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20251030181721/en/

"Over the last three years, we have invested in our business to better support our clients and fuel innovation in healthcare. These new team moves are the next step in our business evolution," said Tim Scallen, chief executive officer of Bailey & Company.